Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) traded down 5.3% on Monday following insider selling activity. Aquestive Therapeutics Price PerformanceThe firm has a market cap of $563.42 million, a price-to-earnings ratio of -8.07 and a beta of 1.82. Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) last released its quarterly earnings results on Monday, August 11th. As a group, equities research analysts predict that Aquestive Therapeutics, Inc. will post -0.46 earnings per share for the current year. Read MoreReceive News & Ratings for Aquestive Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquestive Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.